Health Highlights, April 7, 2022

Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
Related Posts
FDA Moves to Ease Restrictions on Gay Men Giving Blood
THURSDAY, Dec. 1, 2022 (HealthDay News) -- U.S. Food & Drug Administration...
¿Cuáles nuevas mamás tienen el riesgo más alto de depresión postparto?
LUNES, 28 de febrero de 2022 (HealthDay News) -- Las mamás primerizas y las...
Overall Cancer Mortality Continued to Decline From 2019 to 2020
THURSDAY, Jan. 12, 2023 (HealthDay News) -- Overall cancer mortality is...
Inequalities in Human Resources for Health Linked to Mortality
MONDAY, May 15, 2023 (HealthDay News) -- Inequalities in human resources for...